Cyclodextrins in non-viral gene delivery

被引:106
|
作者
Lai, Wing-Fu [1 ]
机构
[1] Yonsei Univ, Coll Dent, Dept Oral Biol, Div Anat & Dev Biol, Seoul 120749, South Korea
关键词
Cyclodextrin; Gene delivery; Non-viral vector; Polymer; Transfection; NUCLEIC-ACID DELIVERY; BETA-CYCLODEXTRIN; ALPHA-CYCLODEXTRIN; IN-VIVO; POLYAMIDOAMINE DENDRIMER; OLIGONUCLEOTIDE DELIVERY; PLASMID DNA; PHARMACEUTICAL APPLICATIONS; ABSORPTION ENHANCER; CONTAINING POLYMERS;
D O I
10.1016/j.biomaterials.2013.09.061
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Cyclodextrins (CDs) are naturally occurring cyclic oligosaccharides. They consist of (alpha-1,4)-linked glucose units, and possess a basket-shaped topology with an "inner-outer" amphiphilic character. Over the years, substantial efforts have been undertaken to investigate the possible use of CDs in drug delivery and controlled drug release, yet the potential of CDs in gene delivery has received comparatively less discussion in the literature. In this article, we will first discuss the properties of CDs for gene delivery, followed by a synopsis of the use of CDs in development and modification of non-viral gene carriers. Finally, areas that are noteworthy in CD-based gene delivery will be highlighted for future research. Due to the application prospects of CDs, it is anticipated that CDs will continue to emerge as an important tool for vector development, and will play significant roles in facilitating non-viral gene delivery in the forthcoming decades. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:401 / 411
页数:11
相关论文
共 50 条
  • [41] Micro- and nanobubbles: A versatile non-viral platform for gene delivery
    Cavalli, Roberta
    Bisazza, Agnese
    Lembo, David
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 456 (02) : 437 - 445
  • [42] In vivo gene delivery mediated by non-viral vectors for cancer therapy
    Mohammadinejad, Reza
    Dehshahri, Ali
    Madamsetty, Vijay Sagar
    Zahmatkeshan, Masoumeh
    Tavakol, Shima
    Makvandi, Pooyan
    Khorsandi, Danial
    Pardakhty, Abbas
    Ashrafizadeh, Milad
    Afshar, Elham Ghasemipour
    Zarrabi, Ali
    JOURNAL OF CONTROLLED RELEASE, 2020, 325 : 249 - 275
  • [43] Development of non-viral vectors for systemic gene delivery
    Liu, F
    Huang, L
    JOURNAL OF CONTROLLED RELEASE, 2002, 78 (1-3) : 259 - 266
  • [44] DENDRITIC ARCHITECTURES AS NON-VIRAL GENE DELIVERY VECTORS: CHALLENGES AND PERSPECTIVES
    Rusu, Radu Dan
    Clima, Lilia
    Pinteala, Mariana
    REVUE ROUMAINE DE CHIMIE, 2018, 63 (7-8) : 581 - 592
  • [45] Intracellular organelle-targeted non-viral gene delivery systems
    Won, Young-Wook
    Lim, Kwang Suk
    Kim, Yong-Hee
    JOURNAL OF CONTROLLED RELEASE, 2011, 152 (01) : 99 - 109
  • [46] Non-viral nanovectors for gene delivery: factors that govern successful therapeutics
    Viola, Joana R.
    El-Andaloussi, Samir
    Oprea, Iulian I.
    Smith, C. I. Edvard
    EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (06) : 721 - 735
  • [47] Recent progress in gene delivery using non-viral transfer complexes
    Godbey, WT
    Mikos, AG
    JOURNAL OF CONTROLLED RELEASE, 2001, 72 (1-3) : 115 - 125
  • [48] Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems
    Rezaee, Mehdi
    Oskuee, Reza Kazemi
    Nassirli, Hooriyeh
    Malaekeh-Nikouei, Bizhan
    JOURNAL OF CONTROLLED RELEASE, 2016, 236 : 1 - 14
  • [49] Non-viral gene delivery: from the needle to the nucleus
    Rettig, Garrett R.
    Rice, Kevin G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (06) : 799 - 808
  • [50] Tailoring quaternized starch as a non-viral carrier for gene delivery applications
    Sieradzki, Rivka
    Traitel, Tamar
    Goldbart, Riki
    Geresh, Shimona
    Kost, Joseph
    POLYMERS FOR ADVANCED TECHNOLOGIES, 2014, 25 (05) : 552 - 561